Chinese Journal of Tissue Engineering Research ›› 2016, Vol. 20 ›› Issue (19): 2817-2823.doi: 10.3969/j.issn.2095-4344.2016.19.012

Previous Articles     Next Articles

Umbilical cord blood mesenchymal stem cell transplantation for acute intestinal ischemia-reperfusion injury

Wang Bing-jie1, Hu Yan-wei2, Zhao Ye-fang3, Zhang Shi-dong2   

  1. 1Department of Anorectal Surgery, 2Department of General Surgery, 3Department of Obstetrics and Gynecology, Affiliated Xingtai People's Hospital of Hebei Medical University, Xingtai 054001, Hebei Province, China
  • Received:2016-03-02 Online:2016-05-06 Published:2016-05-06
  • About author:Wang Bing-jie, Master, Attending physician, Department of Anorectal Surgery, Affiliated Xingtai People's Hospital of Hebei Medical University, Xingtai 054001, Hebei Province, China

Abstract:

BACKGROUND: Bone marrow mesenchymal stem cells can repair intestinal ischemia-reperfusion injuny by interfering inflammatory reactions after intestinal ischemia-reperfusion to protect intestinal barrier functions. In recent years, umbilical cord blood mesenchymal stem cells are gradually used as a substitute source of bone marrow mesenchymal stem cells.
OBJECTIVE: To investigate the effects of umbilical cord blood mesenchymal stem cells on acute intestinal ischemia-reperfusion injury.
METHODS: Umbilical cord blood mesenchymal stem cells were induced, isolated in vitro and tracked by CM-DiI fluorescent labeling. Sixty-three Sprague-Dawley rats were equivalently randomized into three groups: control group received normal saline enema, intestinal ischemia-reperfusion injury group with ethanol diluted trinitro-benzene-sulfonic acid and transplantation group administrated with 1×1010/L umbilical cord blood mesenchymal stem cell suspension via the tail vein at 1 hour after trinitro-benzene-sulfonic acid modeling. At 3 days after transplantation, colon tissues were removed in each group to observe pathological changes of the intestinal tract by hematoxylin-eosin staining. Besides, expression of leptin mRNA in the colon tissues and cyclooxygenase-2 in the mucosa were detected by RT-PCR and immunohistochemistry method, respectively.
RESULTS AND CONCLUSION: Transplanted umbilical cord blood mesenchymal stem cells distributed in the intestinal lymphoid tissue and among glandular epithelial cells, suggesting that these stem cells might be involved in the process of intestinal ischemia-reperfusion injury repair. Compared with the control group, intestinal injury in the injury group was significantly aggravated, and most intestinal epithelial cells shed; and the transplantation group appeared to have significantly reduced intestinal damage and significantly less cell shedding. Expression of leptin mRNA was significantly higher in the injury group than the transplantation group followed by the control group, and there were significant differences among the three groups (P < 0.05). Additionally, expression of cyclooxygenase-2 in the injury group was significantly higher than that in the control group (P < 0.05); compared with the injury group, expression of cyclooxygenase-2 was significantly lower in the transplantation group (P < 0.05). To conclude, leptin and cyclooxygenase-2 may be involved in acute intestinal ischemia-reperfusion injury, and umbilical cord blood mesenchymal stem cell transplantation significantly lessens intestinal ischemia-reperfusion injury, which provides an experimental basis for human treating acute intestinal ischemic injury.

 

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

Key words: Stem Cells, Cord blood Cell Transplantation, Mesenchymal Stem Cells, Reperfusion Injury, Tissue Engineering

CLC Number: